A review on the policy environment of innovative drug market access: A stakeholder's perspective
10.3969/j.issn.1674-2982.2017.08.006
- VernacularTitle:创新药物市场准入政策环境研究——基于利益相关者视角
- Author:
zhen Shu CHU
1
;
nan En WANG
;
jun Zi YU
Author Information
1. 中国药科大学国际医药商学院 江苏南京 211198
- Keywords:
Stakeholders;
Innovative drugs;
Access to market
- From:
Chinese Journal of Health Policy
2017;10(8):29-33
- CountryChina
- Language:Chinese
-
Abstract:
Based on the stakeholder theory,externalities theory and marginal utility theory,this paper analyzes the behavioral needs of stakeholders in the process of market access of innovative drugs.It also draws out the core of the government and the pharmaceutical enterprises in the policy of access to innovative drug market and supply to the community,the patients,and the medical institutions enter the mechanism of the interaction of the various stakeholders in the innovative drug market for the demand community and construct the above-mentioned stakeholder perspective Innovative Drug Market Access Policy Environment Model.Based on the status quo of China's innovative drug market access,the present study puts forward to encourage innovative drug market access to the interests of the main body,to optimize the existing innovative drug market access policy environment to make reference recommendations.
